- Home
- FTCI vs TCRX Comparison
FTCI vs TCRX Comparison
Compare FTCI & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTCI
- TCRX
- Stock Information
- Founded
- FTCI 2017
- TCRX 2018
- Country
- FTCI United States
- TCRX United States
- Employees
- FTCI N/A
- TCRX N/A
- Industry
- FTCI Semiconductors
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- FTCI Technology
- TCRX Health Care
- Exchange
- FTCI Nasdaq
- TCRX Nasdaq
- Market Cap
- FTCI 93.0M
- TCRX 91.7M
- IPO Year
- FTCI 2021
- TCRX 2021
- Fundamental
- Price
- FTCI $6.93
- TCRX $1.72
- Analyst Decision
- FTCI Buy
- TCRX Strong Buy
- Analyst Count
- FTCI 3
- TCRX 5
- Target Price
- FTCI $4.67
- TCRX $9.40
- AVG Volume (30 Days)
- FTCI 63.2K
- TCRX 218.2K
- Earning Date
- FTCI 11-11-2025
- TCRX 11-11-2025
- Dividend Yield
- FTCI N/A
- TCRX N/A
- EPS Growth
- FTCI N/A
- TCRX N/A
- EPS
- FTCI N/A
- TCRX N/A
- Revenue
- FTCI $64,134,000.00
- TCRX $6,961,000.00
- Revenue This Year
- FTCI $90.77
- TCRX $255.18
- Revenue Next Year
- FTCI $130.32
- TCRX N/A
- P/E Ratio
- FTCI N/A
- TCRX N/A
- Revenue Growth
- FTCI N/A
- TCRX N/A
- 52 Week Low
- FTCI $2.13
- TCRX $1.02
- 52 Week High
- FTCI $7.40
- TCRX $6.23
- Technical
- Relative Strength Index (RSI)
- FTCI 53.74
- TCRX 43.84
- Support Level
- FTCI N/A
- TCRX $1.73
- Resistance Level
- FTCI $7.25
- TCRX $1.96
- Average True Range (ATR)
- FTCI 0.43
- TCRX 0.11
- MACD
- FTCI -0.22
- TCRX -0.02
- Stochastic Oscillator
- FTCI 95.59
- TCRX 22.58
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.